Qi Diagnostics was founded by two biologists, Grover and Kenneth, who previously worked together at an international biotech company responsible for genetic testing. They discovered that existing disease detection methods had many drawbacks, including being invasive, time-consuming, and expensive. As a result, they began researching painless, low-cost, and quick testing methods to help more people detect and treat health issues early on.
Who we are
Breath nano-sensors developer
- After countless nights of reading research papers and conducting experiments, they discovered that breath analysis could be used to examine the body. In 2018, they founded Qi Diagnostics to develop non-invasive breath-based cancer detection technology that could detect body conditions by analyzing the gases exhaled by the body. This technology could help people detect diseases early and seek preventive measures and treatment.
- As the breath-based technology began to take shape, more people became interested and supportive of the company's efforts. In 2020, Qi Diagnostics expanded its research scope to include health management and developed KetoAir, a breath monitoring device that helps individuals monitor their ketogenic state to maintain their health.
- In the future, Qi Diagnostics will continue to focus on developing more advanced and accurate breath-based testing technology in both medical and health management fields. The company aims to introduce more time-saving, convenient, and non-invasive products to benefit more people and achieve the goal of maintaining a healthy lifestyle through early detection and treatment.
mission
Target for best support
Develop affordable non-invasive portable devices for personal health monitoring and early disease detection.
Vision
Our goals for success
Prevent sickness through sustaining health, reduce death by early diagnosis
Our Founder
Founder
Dr. KAM Wan Lung Kenneth
PhD (HKU), Mphil (HKUST)
Former Vice President in BGI with 15 years of experiences in clinical product research and development. Managed research and cross fields collaboration projects.
Founder
CHEUNG Wai Fung Grover
Master in Business Management of Imperial College London.
Former Regional Manager in BGI with 11 years of experiences in clinical testing and research service. Managed teams of sales and technical supports in NIPT, NGS research, cancer testing and etc.